The biotech stock's price-to-earnings-to-growth (PEG) ratio is a super-low 0.58, according to the London Stock Exchange Group (LSEG). Any PEG ratio below 1.0 is viewed as an attractive valuation.

Dr Vivienne Cox, who worked for two major pharmaceutical companies and co-founded two biotech firms, believes the 5:2 diet ...

The U.S. is one of only two countries that legally allows drugmakers to advertise products directly to patients. There are ...

With the opening of classes in the country last month coinciding with the start of the rainy season, there is a higher risk ...

Nvidia has been the hottest stock since the start of the AI revolution, and I see one particular healthcare business ...

The Drugs Controller General of India (DCGI) has declared as many as 16 commonly-used medicines as spurious, after they ...

The GSK share price has had a rotten few years and now it's heading south yet again. Investor Harvey Jones continues to hang ...

Each year, the National Drug and Alcohol Research Center at UNSW Sydney surveys hundreds of people who regularly use drugs in ...

Safaricom explains its role in the new health insurance programme, to support the Ministry of Health through the Integrated ...

I have questions about whether groundnut oil is safe. Yes, it is. It is heart-friendly. However, you should make sure that it ...

This year's spike in cases marks a return to pre-pandemic levels of this infection, which is also called pertussis.

Health Minister Mark Butler has declined to say how the government intends to respond to a damning report that found both the health system and workplaces were failing women.